2000
DOI: 10.1002/1096-8628(20001113)95:2<108::aid-ajmg4>3.0.co;2-0
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1

Abstract: Although it is well recognized that a peripheral vasculopathy may occur in patients with neurofibromatosis 1 (NF1), it is unclear whether cardiovascular abnormalities are more common. We reviewed the frequency of cardiovascular abnormalities, in particular, cardiovascular malformations (CVMs), among 2322 patients with definite NF1 in the National Neurofibromatosis Foundation International Database from 1991-98. Cardiovascular malformations were reported in 54/2322 (2.3%) of the NF1 patients, only 4 of whom had… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

11
177
0
12

Year Published

2000
2000
2020
2020

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 219 publications
(200 citation statements)
references
References 52 publications
11
177
0
12
Order By: Relevance
“…In 28 of them, information regarding the cardiac status was available. The difference in PS prevalence between the NFNS group and the NF1 group, was shown to be driven by the NFNS patients with non-truncating mutation: 66.7% (8/12) of NFNS with non-truncating mutation patients had PS vs 1.1% (25/2322) 23 in NF1 (Po0.001, LR ¼ 55); only 6.2% (1/16) NFNS patients with a truncating mutation had PS, not significantly different from NF1 patients: 1.1% (P ¼ 0.164) ( Table 1).…”
Section: Resultsmentioning
confidence: 93%
See 3 more Smart Citations
“…In 28 of them, information regarding the cardiac status was available. The difference in PS prevalence between the NFNS group and the NF1 group, was shown to be driven by the NFNS patients with non-truncating mutation: 66.7% (8/12) of NFNS with non-truncating mutation patients had PS vs 1.1% (25/2322) 23 in NF1 (Po0.001, LR ¼ 55); only 6.2% (1/16) NFNS patients with a truncating mutation had PS, not significantly different from NF1 patients: 1.1% (P ¼ 0.164) ( Table 1).…”
Section: Resultsmentioning
confidence: 93%
“…No clear genotype-phenotype correlation for the cardiac phenotype in NF1 and/or NFNS has been suggested, although a trend of association was found between heart defects, NFNS and in-frame/single amino-acid substitution. 18 Given the previous observations of an increased prevalence of nontruncating mutations in NFNS, 18 of an excess of PS in patients with NF1, 23 particularly in patients with the non-truncating 3 bp exon 17 deletion, 9 we hypothesized that non-truncating mutations in NF1 may be responsible for particular disease features, especially those which overlap with other Ras-MAPK disorders. Here, we report our analysis of mutation type in patients with PS and NF1, WS or NFNS.…”
Section: Introductionmentioning
confidence: 97%
See 2 more Smart Citations
“…The frequency of vascular lesions in NF1 patients is hard to define because screening studies are not routinely performed, but the prevalence of vascular lesions in large series is 0.4% to 6.4%. 3,4,11,14) Renal artery lesions are most common (41%) and are more often stenotic than aneurysmal, but carotid artery, vertebral artery (VA), and cerebral artery aneurysms, reported in 46 patients, occur in the third decade of life and are more common in women. The renal artery is most frequently involved, resulting in renovascular hypertension.…”
Section: Introductionmentioning
confidence: 99%